Joel David Mayersohn
Director · CITIUS ONCOLOGY, INC.
Individual
- 2024
- Dec 22, 2025
- 5
Filings (90d)
Other insiders active in the same sector
No other insider has filed at Joel David Mayersohn's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Frank Torti - $82.04M in ROIV purchases and sales in the last 12 months
- ILLUMINA, INC. - $79.85M in GRAL purchases and sales in the last 12 months
- Darren M. Black - $77.56M in LFST purchases and sales in the last 12 months
- Noubar Afeyan - $75.00M in GENB purchases and sales in the last 12 months
- Andrew J. Mills - $75.00M in MDLN purchases and sales in the last 12 months
- Charles N. Mills - $74.80M in MDLN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Joel David Mayersohn?
Joel David Mayersohn is a corporate insider, tracked as Director of CITIUS ONCOLOGY, INC. (CTOR). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Joel David Mayersohn last file a Form 4?
The most recent primary Form 4 on record is dated 22 December 2025, one of 5 filings going back to 2024.
